Acitretin
350
relevant articles (62 outcomes,
37 trials/studies)
found for this Drug
Description:
An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of ETRETINATE with the advantage of a much shorter half-life when compared with etretinate.
Also Known As:
Acitretin, (Z,E,E,E)-Isomer; Andreu Brand of Acitretin; Hoffmann-La Roche Brand of Acitretin; Isoacitretin; Neotigason; Ro 10-1670; Ro 13-7652; Ro-10-1670; Ro-13-7652; Roche Brand of Acitretin; Soriatane; Acitretin Andreu Brand; Acitretin Roche Brand; Ro 101670; Ro 137652; Ro101670; Ro137652; 13-cis-Acitretin; Etretin; Isoetretin; 2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (all-E)-
Relationship Network
Drug Context: Research Results
Experts
| 1. | Pearce, Daniel J:
4 articles
(10/2008 - 01/2006)
|
| 2. | Feldman, Steven R:
4 articles
(10/2008 - 01/2006)
|
| 3. | Koo, John:
3 articles
(07/2008 - 08/2005)
|
| 4. | Girolomoni, G:
3 articles
(06/2008 - 09/2003)
|
| 5. | Yelverton, Christopher B:
2 articles
(10/2008 - 09/2008)
|
| 6. | Fleischer, Alan B:
2 articles
(10/2008 - 09/2008)
|
| 7. | Boles, Ann:
2 articles
(10/2008 - 09/2008)
|
| 8. | Balkrishnan, Rajesh:
2 articles
(10/2008 - 09/2008)
|
| 9. | Camacho, Fabian T:
2 articles
(10/2008 - 09/2008)
|
| 10. | Clark, Adele:
2 articles
(10/2008 - 09/2008)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures